13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages
•13MP reduced the malignant behaviors of NSCLC cells.•13MP promoted TAM from M2 to M1 polarization.•13MP attenuated M2-TAM-mediated NSCLC progression.•13MP repressed M2-TAM-mediated angiogenesis.•13MP abated the M2-TAM-mediated the PI3K/AKT and JAK/STAT3 pathway activation. Previous studies have sub...
Saved in:
Published in | International immunopharmacology Vol. 104; p. 108468 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.03.2022
Elsevier BV |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •13MP reduced the malignant behaviors of NSCLC cells.•13MP promoted TAM from M2 to M1 polarization.•13MP attenuated M2-TAM-mediated NSCLC progression.•13MP repressed M2-TAM-mediated angiogenesis.•13MP abated the M2-TAM-mediated the PI3K/AKT and JAK/STAT3 pathway activation.
Previous studies have substantiated that M2-activated tumor-associated macrophages (M2-TAMs) are involved in multiple malignancies. Presently, we probe the impact and related mechanisms of 13-methyl-palmatrubine (13MP), the Corydalis yanhusuo extract, on M2-TAM-mediated non-small cell lung cancer (NSCLC) development.
IL-4 and IL-13 were adopted to induce M2-TAMs. The polarization state of TAMs was evaluated by quantitative reverse transcription PCR (qRT-PCR), Western blot (WB) and cellular immunofluorescence. NSCLC cells (A549 and NCL-H1975) were co-cultured with the conditioned medium (CM) of M2-TAMs. Followed by 13MP treatment, cell viability, proliferation, invasion, epithelial-mesenchymal transition (EMT), and in-vivo growth of NSCLC cells were determined. Additionally, human umbilical vein endothelial cells (HUVECs) were co-cultured with the CM of M2-TAMs. The tube formation assay was made to test the tube formation capacity of HUVECs, and the expression of MMP3, MMP9, and VEGF was assessed by WB in the co-culture model. Mechanistically, WB was performed to validate the expression of the PI3K/AKT and JAK/STAT3 pathways in NSCLC cells (A549 and NCL-H1975) as well as in endothelial cell lines co-cultured with M2-TAMs.
13MP inhibited the proliferation, invasion, EMT, growth and enhanced apoptosis of NSCLC cells. 13MP dose-dependently boosted the polarization of TAM from M2 to M1 state. M2-TAMs enhanced the malignant behaviors of NSCLC cells, whereas 13MP hindered M2-TAM-mediated NSCLC cell proliferation and invasion. Meanwhile, 13MP weakened the M2-TAM-mediated angiogenesis. Moreover, 13MP inactivated the PI3K/AKT and JAK/STAT3 signaling in A549 cells, NCL-H1975 cells and HUVECs.
13MP suppresses TAM-mediated NSCLC progression via transforming the polarization of TAM from M2 to M1. |
---|---|
AbstractList | Previous studies have substantiated that M2-activated tumor-associated macrophages (M2-TAMs) are involved in multiple malignancies. Presently, we probe the impact and related mechanisms of 13-methyl-palmatrubine (13MP), the Corydalis yanhusuo extract, on M2-TAM-mediated non-small cell lung cancer (NSCLC) development.
IL-4 and IL-13 were adopted to induce M2-TAMs. The polarization state of TAMs was evaluated by quantitative reverse transcription PCR (qRT-PCR), Western blot (WB) and cellular immunofluorescence. NSCLC cells (A549 and NCL-H1975) were co-cultured with the conditioned medium (CM) of M2-TAMs. Followed by 13MP treatment, cell viability, proliferation, invasion, epithelial-mesenchymal transition (EMT), and in-vivo growth of NSCLC cells were determined. Additionally, human umbilical vein endothelial cells (HUVECs) were co-cultured with the CM of M2-TAMs. The tube formation assay was made to test the tube formation capacity of HUVECs, and the expression of MMP3, MMP9, and VEGF was assessed by WB in the co-culture model. Mechanistically, WB was performed to validate the expression of the PI3K/AKT and JAK/STAT3 pathways in NSCLC cells (A549 and NCL-H1975) as well as in endothelial cell lines co-cultured with M2-TAMs.
13MP inhibited the proliferation, invasion, EMT, growth and enhanced apoptosis of NSCLC cells. 13MP dose-dependently boosted the polarization of TAM from M2 to M1 state. M2-TAMs enhanced the malignant behaviors of NSCLC cells, whereas 13MP hindered M2-TAM-mediated NSCLC cell proliferation and invasion. Meanwhile, 13MP weakened the M2-TAM-mediated angiogenesis. Moreover, 13MP inactivated the PI3K/AKT and JAK/STAT3 signaling in A549 cells, NCL-H1975 cells and HUVECs.
13MP suppresses TAM-mediated NSCLC progression via transforming the polarization of TAM from M2 to M1. •13MP reduced the malignant behaviors of NSCLC cells.•13MP promoted TAM from M2 to M1 polarization.•13MP attenuated M2-TAM-mediated NSCLC progression.•13MP repressed M2-TAM-mediated angiogenesis.•13MP abated the M2-TAM-mediated the PI3K/AKT and JAK/STAT3 pathway activation. Previous studies have substantiated that M2-activated tumor-associated macrophages (M2-TAMs) are involved in multiple malignancies. Presently, we probe the impact and related mechanisms of 13-methyl-palmatrubine (13MP), the Corydalis yanhusuo extract, on M2-TAM-mediated non-small cell lung cancer (NSCLC) development. IL-4 and IL-13 were adopted to induce M2-TAMs. The polarization state of TAMs was evaluated by quantitative reverse transcription PCR (qRT-PCR), Western blot (WB) and cellular immunofluorescence. NSCLC cells (A549 and NCL-H1975) were co-cultured with the conditioned medium (CM) of M2-TAMs. Followed by 13MP treatment, cell viability, proliferation, invasion, epithelial-mesenchymal transition (EMT), and in-vivo growth of NSCLC cells were determined. Additionally, human umbilical vein endothelial cells (HUVECs) were co-cultured with the CM of M2-TAMs. The tube formation assay was made to test the tube formation capacity of HUVECs, and the expression of MMP3, MMP9, and VEGF was assessed by WB in the co-culture model. Mechanistically, WB was performed to validate the expression of the PI3K/AKT and JAK/STAT3 pathways in NSCLC cells (A549 and NCL-H1975) as well as in endothelial cell lines co-cultured with M2-TAMs. 13MP inhibited the proliferation, invasion, EMT, growth and enhanced apoptosis of NSCLC cells. 13MP dose-dependently boosted the polarization of TAM from M2 to M1 state. M2-TAMs enhanced the malignant behaviors of NSCLC cells, whereas 13MP hindered M2-TAM-mediated NSCLC cell proliferation and invasion. Meanwhile, 13MP weakened the M2-TAM-mediated angiogenesis. Moreover, 13MP inactivated the PI3K/AKT and JAK/STAT3 signaling in A549 cells, NCL-H1975 cells and HUVECs. 13MP suppresses TAM-mediated NSCLC progression via transforming the polarization of TAM from M2 to M1. Background Previous studies have substantiated that M2-activated tumor-associated macrophages (M2-TAMs) are involved in multiple malignancies. Presently, we probe the impact and related mechanisms of 13-methyl-palmatrubine (13MP), the Corydalis yanhusuo extract, on M2-TAM-mediated non-small cell lung cancer (NSCLC) development. Methods IL-4 and IL-13 were adopted to induce M2-TAMs. The polarization state of TAMs was evaluated by quantitative reverse transcription PCR (qRT-PCR), Western blot (WB) and cellular immunofluorescence. NSCLC cells (A549 and NCL-H1975) were co-cultured with the conditioned medium (CM) of M2-TAMs. Followed by 13MP treatment, cell viability, proliferation, invasion, epithelial-mesenchymal transition (EMT), and in-vivo growth of NSCLC cells were determined. Additionally, human umbilical vein endothelial cells (HUVECs) were co-cultured with the CM of M2-TAMs. The tube formation assay was made to test the tube formation capacity of HUVECs, and the expression of MMP3, MMP9, and VEGF was assessed by WB in the co-culture model. Mechanistically, WB was performed to validate the expression of the PI3K/AKT and JAK/STAT3 pathways in NSCLC cells (A549 and NCL-H1975) as well as in endothelial cell lines co-cultured with M2-TAMs. Results 13MP inhibited the proliferation, invasion, EMT, growth and enhanced apoptosis of NSCLC cells. 13MP dose-dependently boosted the polarization of TAM from M2 to M1 state. M2-TAMs enhanced the malignant behaviors of NSCLC cells, whereas 13MP hindered M2-TAM-mediated NSCLC cell proliferation and invasion. Meanwhile, 13MP weakened the M2-TAM-mediated angiogenesis. Moreover, 13MP inactivated the PI3K/AKT and JAK/STAT3 signaling in A549 cells, NCL-H1975 cells and HUVECs. Conclusion 13MP suppresses TAM-mediated NSCLC progression via transforming the polarization of TAM from M2 to M1. BACKGROUNDPrevious studies have substantiated that M2-activated tumor-associated macrophages (M2-TAMs) are involved in multiple malignancies. Presently, we probe the impact and related mechanisms of 13-methyl-palmatrubine (13MP), the Corydalis yanhusuo extract, on M2-TAM-mediated non-small cell lung cancer (NSCLC) development.METHODSIL-4 and IL-13 were adopted to induce M2-TAMs. The polarization state of TAMs was evaluated by quantitative reverse transcription PCR (qRT-PCR), Western blot (WB) and cellular immunofluorescence. NSCLC cells (A549 and NCL-H1975) were co-cultured with the conditioned medium (CM) of M2-TAMs. Followed by 13MP treatment, cell viability, proliferation, invasion, epithelial-mesenchymal transition (EMT), and in-vivo growth of NSCLC cells were determined. Additionally, human umbilical vein endothelial cells (HUVECs) were co-cultured with the CM of M2-TAMs. The tube formation assay was made to test the tube formation capacity of HUVECs, and the expression of MMP3, MMP9, and VEGF was assessed by WB in the co-culture model. Mechanistically, WB was performed to validate the expression of the PI3K/AKT and JAK/STAT3 pathways in NSCLC cells (A549 and NCL-H1975) as well as in endothelial cell lines co-cultured with M2-TAMs.RESULTS13MP inhibited the proliferation, invasion, EMT, growth and enhanced apoptosis of NSCLC cells. 13MP dose-dependently boosted the polarization of TAM from M2 to M1 state. M2-TAMs enhanced the malignant behaviors of NSCLC cells, whereas 13MP hindered M2-TAM-mediated NSCLC cell proliferation and invasion. Meanwhile, 13MP weakened the M2-TAM-mediated angiogenesis. Moreover, 13MP inactivated the PI3K/AKT and JAK/STAT3 signaling in A549 cells, NCL-H1975 cells and HUVECs.CONCLUSION13MP suppresses TAM-mediated NSCLC progression via transforming the polarization of TAM from M2 to M1. |
ArticleNumber | 108468 |
Author | Li, Wencan Wu, Zhihui Zhou, Juan Chen, Fangwei Yu, Jing Li, Hui Li, Qingfeng |
Author_xml | – sequence: 1 givenname: Zhihui surname: Wu fullname: Wu, Zhihui organization: Department of Thoracic Surgery, Zhuzhou Central Hospital, Zhuzhou 412000, China – sequence: 2 givenname: Juan surname: Zhou fullname: Zhou, Juan organization: Department of Pulmonary and Critical Care Medicine 1, Zhuzhou Central Hospital, Zhuzhou 412000, China – sequence: 3 givenname: Fangwei surname: Chen fullname: Chen, Fangwei organization: Department of Pulmonary and Critical Care Medicine 1, Zhuzhou Central Hospital, Zhuzhou 412000, China – sequence: 4 givenname: Jing surname: Yu fullname: Yu, Jing organization: Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, Hubei, China – sequence: 5 givenname: Hui surname: Li fullname: Li, Hui organization: Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, Hubei, China – sequence: 6 givenname: Qingfeng surname: Li fullname: Li, Qingfeng organization: Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, Hubei, China – sequence: 7 givenname: Wencan surname: Li fullname: Li, Wencan email: Lwccom@sina.com organization: Department of Thoracic Surgery, Zhuzhou Central Hospital, Zhuzhou 412000, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35066343$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU2L1TAUhoOMOB_6D0QCbtz0mpO0SbsRZPAL5uJG1yFNT-fm0iY1SWcY9_5vc-nowoUQknB4zns-3kty5oNHQl4C2wED-fa4cz67edlxxqGE2lq2T8gFtKqtQLHmrPwbqapGye6cXKZ0ZKzEa3hGzkXDpBS1uCC_QFR7zIeHqVrMNJsc1955pOkQ7hM1vpzsqrzOIdIYJqTO09JIlWYzTdRiuabV31JrvMVI75wpqW7MrsT2nOZA90CXMJnofprsgqdhpJvcbGwMy8HcYnpOno5mSvji8b0i3z9--Hb9ubr5-unL9fubyoqO5QqMUAq4UgOX1kgloIPOYmeYFVj30Es5St60ZQVCmp6L3nTNYLuBQz_WrBFX5M2mu8TwY8WU9ezSaQjjMaxJc8l5rTjnqqCv_0GPYY2-dFco0SmAWslC1RtVRkkp4qiX6GYTHzQwfbJJH_Vmkz7ZpDebStqrR_G1n3H4m_THlwK82wAs27hzGHWyDsuKBxfRZj0E9_8KvwGIuabj |
CitedBy_id | crossref_primary_10_1016_j_envres_2023_115942 crossref_primary_10_1016_j_biopha_2023_114980 crossref_primary_10_1016_j_biopha_2023_116014 crossref_primary_10_3390_ijtm4030029 crossref_primary_10_3892_ol_2022_13476 |
Cites_doi | 10.1016/j.cpet.2017.09.004 10.1186/s12906-019-2739-6 10.5604/17322693.1150133 10.1016/j.cellimm.2016.11.002 10.2174/156800908784293659 10.1016/j.soc.2016.02.001 10.18632/oncotarget.9079 10.3892/or.2016.5093 10.1111/cas.14230 10.1007/s12272-016-0820-y 10.1186/s12885-015-1546-9 10.18632/oncotarget.16471 10.1093/cvr/cvt073 10.1080/10286020802410615 10.1016/S0140-6736(14)62038-9 10.3892/ijo.2017.3841 10.3390/molecules23040714 10.1142/S0192415X11009044 10.1200/EDBK_201231 10.1016/j.imbio.2013.06.011 10.1038/s41419-019-1618-x 10.1002/jcp.26429 10.1016/j.phrs.2018.05.002 10.1016/j.soc.2016.02.011 10.1016/j.ejca.2006.01.003 10.3727/096504009789745575 10.1002/path.4860 10.1248/bpb1978.5.469 10.1038/nature25183 10.1158/0008-5472.CAN-16-2874 10.2147/OTT.S210952 10.3322/caac.21166 10.1016/j.intimp.2011.04.022 10.1002/ijc.29210 |
ContentType | Journal Article |
Copyright | 2021 Copyright © 2021. Published by Elsevier B.V. Copyright Elsevier BV Mar 2022 |
Copyright_xml | – notice: 2021 – notice: Copyright © 2021. Published by Elsevier B.V. – notice: Copyright Elsevier BV Mar 2022 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7T5 7U7 7U9 8FD C1K FR3 H94 P64 7X8 |
DOI | 10.1016/j.intimp.2021.108468 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Immunology Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE Virology and AIDS Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1878-1705 |
EndPage | 108468 |
ExternalDocumentID | 10_1016_j_intimp_2021_108468 35066343 S1567576921011048 |
Genre | Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29J 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AAAJQ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATCM AAXUO ABBQC ABFNM ABFRF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACIWK ACPRK ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFRAH AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AI. AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CJTIS CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM L7B LCYCR LUGTX M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SSH SSI SSP SSZ T5K TEORI UNMZH VH1 ZGI ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7T5 7U7 7U9 8FD C1K FR3 H94 P64 7X8 |
ID | FETCH-LOGICAL-c390t-1a3771277d26ca6731919ce9a0c3e4b1b66f625887836ab23ba95dc9d21bf4053 |
IEDL.DBID | AIKHN |
ISSN | 1567-5769 |
IngestDate | Sat Aug 17 03:51:10 EDT 2024 Thu Oct 10 22:21:08 EDT 2024 Thu Sep 26 20:08:52 EDT 2024 Sun Oct 13 10:33:26 EDT 2024 Fri Feb 23 02:43:59 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | 13-Methyl-Palmatrubine Polarization Angiogenesis Non-small cell lung cancer Macrophage |
Language | English |
License | Copyright © 2021. Published by Elsevier B.V. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c390t-1a3771277d26ca6731919ce9a0c3e4b1b66f625887836ab23ba95dc9d21bf4053 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 35066343 |
PQID | 2639711476 |
PQPubID | 2045469 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2622472227 proquest_journals_2639711476 crossref_primary_10_1016_j_intimp_2021_108468 pubmed_primary_35066343 elsevier_sciencedirect_doi_10_1016_j_intimp_2021_108468 |
PublicationCentury | 2000 |
PublicationDate | March 2022 2022-Mar 2022-03-00 20220301 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: March 2022 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: Amsterdam |
PublicationTitle | International immunopharmacology |
PublicationTitleAlternate | Int Immunopharmacol |
PublicationYear | 2022 |
Publisher | Elsevier B.V Elsevier BV |
Publisher_xml | – name: Elsevier B.V – name: Elsevier BV |
References | Juhas, Ryba-Stanisławowska, Szargiej, Myśliwska (b0160) 2015 Apr; 22 Guan, Wang, Fu, Pang, Lou, Li (b0190) 2019; 20 Siegel, Naishadham, Jemal (b0015) 2013; 63 Shapouri-Moghaddam, Mohammadian, Vazini, Taghadosi, Esmaeili, Mardani, Seifi, Mohammadi, Afshari, Sahebkar (b0140) 2018 Sep; 233 Guo, Song, Hao, Zhao, Du, Li, Kuang, Yang, Wang, Deng, Wang (b0155) 2019; 10 Mei, Xiao, Guo, Pu, Ma, Liu, Lin, Liao, You, Liu (b0060) 2016; 7 De Beule, De Veirman, Maes (b0205) 2017; 241 Du, Jin, Li, Wang, Zeng, Jiang, Zhou (b0040) 2018; 23 Naylor, Desani, Chung (b0095) 2016; 25 Herbst, Morgensztern, Boshoff (b0025) 2018; 553 Pöttgen, Eberhardt, Stamatis, Stuschke (b0090) 2017; 8 Sica, Schioppa, Mantovani, Allavena (b0135) 2006; 42 Yao, Zhang, Zhang, Liang, Chen, Yao, Xu, Wu, He, Ding, Yang (b0070) 2018; 133 Gao, Shi, Lee, Zhang, Wang (b0045) 2009; 17 Carnero, Blanco-Aparicio, Renner, Link, Leal (b0180) 2008; 8 Nagy, Czimmerer, Szanto, Nagy (b0165) 2013 Nov; 218 Yuan, Dong, Peng, Yang, Niu, Liu, Xie (b0055) 2019 Johnson, Pennell, Borghaei (b0080) 2018; 38 Cheng, Shi, Zheng, Jin, Sun (b0100) 2008; 10 Quatromoni, Eruslanov (b0130) 2012; 4 Ferlay, Soerjomataram, Dikshit, Eser, Mathers, Rebelo, Parkin, Forman, Bray (b0005) 2015; 136 Wan, Zhao, Zhang, Gao, Zhang, Gao, Chen, Qian (b0105) 2019; 19 Tripathi, Fahrmann, Celiktas (b0185) 2017; 77 Xu, Chen, Zhang, Chen, Wang (b0110) 2011; 39 Kang, Zhang, Wang, Liu, Zhao, Yang, Li (b0150) 2017; 50 Sun, Xu (b0065) 2019; 12 Lee, Cheah (b0085) 2019; 2019 Genin, Clement, Fattaccioli, Raes, Michiels (b0145) 2015 Aug; 8 Rhee (b0125) 2016; 39 Mao, Yang, He, Krasna (b0010) 2016; 25 Gao, Shi, He (b0050) 2008; 20 Chen, Lu, Lu, Wang, Xu, Xu, Gou, Zhu, Du (b0115) 2016; 36 Li, Ji, Niu (b0200) 2020; 111 Akhurst (b0030) 2018; 13 Sun, Chen, Jiang, Li, Wang (b0075) 2017; 311 Namgaladze, Kemmerer, von Knethen, Brüne (b0170) 2013 Jun 1; 98 Allemani, Weir, Carreira (b0020) 2015; 385 Ishiguro, Ando, Maeda, Watanabe, Goto (b0175) 2011 Sep; 11 Kang, Li, Luan (b0195) 2020 Ikekawa, Ikeda (b0120) 1982; 5 Gao, He, Li, Wang (b0035) 2009; 22 Quatromoni (10.1016/j.intimp.2021.108468_b0130) 2012; 4 Cheng (10.1016/j.intimp.2021.108468_b0100) 2008; 10 Naylor (10.1016/j.intimp.2021.108468_b0095) 2016; 25 Shapouri-Moghaddam (10.1016/j.intimp.2021.108468_b0140) 2018; 233 Allemani (10.1016/j.intimp.2021.108468_b0020) 2015; 385 Pöttgen (10.1016/j.intimp.2021.108468_b0090) 2017; 8 Xu (10.1016/j.intimp.2021.108468_b0110) 2011; 39 Wan (10.1016/j.intimp.2021.108468_b0105) 2019; 19 Mei (10.1016/j.intimp.2021.108468_b0060) 2016; 7 Sun (10.1016/j.intimp.2021.108468_b0065) 2019; 12 Chen (10.1016/j.intimp.2021.108468_b0115) 2016; 36 Herbst (10.1016/j.intimp.2021.108468_b0025) 2018; 553 Rhee (10.1016/j.intimp.2021.108468_b0125) 2016; 39 Gao (10.1016/j.intimp.2021.108468_b0045) 2009; 17 Ishiguro (10.1016/j.intimp.2021.108468_b0175) 2011; 11 Tripathi (10.1016/j.intimp.2021.108468_b0185) 2017; 77 Carnero (10.1016/j.intimp.2021.108468_b0180) 2008; 8 Sun (10.1016/j.intimp.2021.108468_b0075) 2017; 311 Ferlay (10.1016/j.intimp.2021.108468_b0005) 2015; 136 Genin (10.1016/j.intimp.2021.108468_b0145) 2015; 8 Gao (10.1016/j.intimp.2021.108468_b0035) 2009; 22 Yuan (10.1016/j.intimp.2021.108468_b0055) 2019 Siegel (10.1016/j.intimp.2021.108468_b0015) 2013; 63 Yao (10.1016/j.intimp.2021.108468_b0070) 2018; 133 Lee (10.1016/j.intimp.2021.108468_b0085) 2019; 2019 Kang (10.1016/j.intimp.2021.108468_b0195) 2020 Sica (10.1016/j.intimp.2021.108468_b0135) 2006; 42 Mao (10.1016/j.intimp.2021.108468_b0010) 2016; 25 Gao (10.1016/j.intimp.2021.108468_b0050) 2008; 20 Akhurst (10.1016/j.intimp.2021.108468_b0030) 2018; 13 Guo (10.1016/j.intimp.2021.108468_b0155) 2019; 10 Nagy (10.1016/j.intimp.2021.108468_b0165) 2013; 218 Johnson (10.1016/j.intimp.2021.108468_b0080) 2018; 38 Namgaladze (10.1016/j.intimp.2021.108468_b0170) 2013; 98 Kang (10.1016/j.intimp.2021.108468_b0150) 2017; 50 Li (10.1016/j.intimp.2021.108468_b0200) 2020; 111 Guan (10.1016/j.intimp.2021.108468_b0190) 2019; 20 Juhas (10.1016/j.intimp.2021.108468_b0160) 2015; 22 Du (10.1016/j.intimp.2021.108468_b0040) 2018; 23 Ikekawa (10.1016/j.intimp.2021.108468_b0120) 1982; 5 De Beule (10.1016/j.intimp.2021.108468_b0205) 2017; 241 |
References_xml | – volume: 19 year: 2019 ident: b0105 article-title: Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling publication-title: BMC Complement Altern. Med. contributor: fullname: Qian – volume: 22 start-page: 1077 year: 2009 end-page: 1083 ident: b0035 article-title: A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity publication-title: Oncol. Rep. contributor: fullname: Wang – volume: 111 start-page: 47 year: 2020 end-page: 58 ident: b0200 article-title: Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer publication-title: Cancer Sci. contributor: fullname: Niu – year: 2019 ident: b0055 article-title: Tumor-associated macrophages affect the biological behavior of lung adenocarcinoma A549 cells through the PI3K/AKT signaling pathway publication-title: Oncol. Lett. contributor: fullname: Xie – volume: 7 start-page: 34217 year: 2016 end-page: 34228 ident: b0060 article-title: Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis publication-title: Oncotarget. contributor: fullname: Liu – volume: 136 start-page: E359 year: 2015 end-page: E386 ident: b0005 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int. J. Cancer. contributor: fullname: Bray – volume: 17 start-page: 519 year: 2009 end-page: 526 ident: b0045 article-title: Angiogenic pathway inhibition of Corydalis yanhusuo and berberine in human umbilical vein endothelial cells publication-title: Oncol. Res. contributor: fullname: Wang – year: 2020 ident: b0195 article-title: NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation [published online ahead of print, 2020 Jun 25] publication-title: Cell Biol Int. contributor: fullname: Luan – volume: 311 start-page: 86 year: 2017 end-page: 93 ident: b0075 article-title: Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages publication-title: Cell Immunol. contributor: fullname: Wang – volume: 2019 start-page: 1 year: 2019 end-page: 12 ident: b0085 article-title: The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression publication-title: J. Immunol. Res. contributor: fullname: Cheah – volume: 39 start-page: 1588 year: 2016 end-page: 1596 ident: b0125 article-title: Diverse macrophages polarization in tumor microenvironment publication-title: Arch. Pharm. Res. contributor: fullname: Rhee – volume: 42 start-page: 717 year: 2006 end-page: 727 ident: b0135 article-title: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy publication-title: Eur. J. Cancer. contributor: fullname: Allavena – volume: 241 start-page: 534 year: 2017 end-page: 546 ident: b0205 article-title: Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation publication-title: J Pathol. contributor: fullname: Maes – volume: 385 start-page: 977 year: 2015 end-page: 1010 ident: b0020 article-title: Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) publication-title: Lancet contributor: fullname: Carreira – volume: 25 start-page: 601 year: 2016 end-page: 609 ident: b0095 article-title: Targeted Therapy and Immunotherapy for Lung Cancer publication-title: Surg. Oncol. Clin. N. Am. contributor: fullname: Chung – volume: 8 start-page: 577 year: 2015 Aug ident: b0145 article-title: M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide publication-title: BMC Cancer. contributor: fullname: Michiels – volume: 20 start-page: 3917 year: 2019 end-page: 3923 ident: b0190 article-title: Increased lncRNA HOTAIR expression promotes the chemoresistance of multiple myeloma to dexamethasone by regulating cell viability and apoptosis by mediating the JAK2/STAT3 signaling pathway publication-title: Mol Med Rep. contributor: fullname: Li – volume: 10 year: 2019 ident: b0155 article-title: M2 macrophages promote NSCLC metastasis by upregulating CRYAB publication-title: Cell Death Dis. contributor: fullname: Wang – volume: 133 start-page: 121 year: 2018 end-page: 131 ident: b0070 article-title: Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages publication-title: Pharmacol. Res. contributor: fullname: Yang – volume: 5 start-page: 469 year: 1982 end-page: 474 ident: b0120 article-title: Antitumor activity of 13-methyl-berberrubine derivatives publication-title: J. Pharmacobiodyn. contributor: fullname: Ikeda – volume: 38 start-page: 696 year: 2018 end-page: 707 ident: b0080 article-title: “My Patient Was Diagnosed With Nontargetable Advanced Non-Small Cell Lung Cancer. What Now?” Diagnosis and Initial Treatment Options for Newly Diagnosed Patients With Advanced NSCLC publication-title: Am. Soc. Clin. Oncol. Educ. Book. contributor: fullname: Borghaei – volume: 12 start-page: 8055 year: 2019 end-page: 8062 ident: b0065 article-title: TCF-4 Regulated lncRNA-XIST Promotes M2 Polarization Of Macrophages And Is Associated With Lung Cancer publication-title: Onco. Targets Ther. contributor: fullname: Xu – volume: 77 start-page: 4414 year: 2017 end-page: 4425 ident: b0185 article-title: MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway publication-title: Cancer Res. contributor: fullname: Celiktas – volume: 553 start-page: 446 year: 2018 end-page: 454 ident: b0025 article-title: The biology and management of non-small cell lung cancer publication-title: Nature contributor: fullname: Boshoff – volume: 13 start-page: 1 year: 2018 end-page: 10 ident: b0030 article-title: Staging of Non-Small-Cell Lung Cancer publication-title: PET Clin. contributor: fullname: Akhurst – volume: 20 start-page: 819 year: 2008 end-page: 824 ident: b0050 article-title: Yanhusuo extract inhibits metastasis of breast cancer cells by modulating mitogen-activated protein kinase signaling pathways publication-title: Oncol. Rep. contributor: fullname: He – volume: 8 start-page: 187 year: 2008 end-page: 198 ident: b0180 article-title: The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications publication-title: Curr Cancer Drug Targets contributor: fullname: Leal – volume: 50 start-page: 545 year: 2017 end-page: 554 ident: b0150 article-title: Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway publication-title: Int. J. Oncol. contributor: fullname: Li – volume: 98 start-page: 479 year: 2013 Jun 1 end-page: 487 ident: b0170 article-title: AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids publication-title: Cardiovasc Res. contributor: fullname: Brüne – volume: 8 start-page: 41670 year: 2017 end-page: 41678 ident: b0090 article-title: Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidence publication-title: Oncotarget contributor: fullname: Stuschke – volume: 11 start-page: 1362 year: 2011 Sep end-page: 1367 ident: b0175 article-title: Dehydrocorydaline inhibits elevated mitochondrial membrane potential in lipopolysaccharide-stimulated macrophages publication-title: Int Immunopharmacol. contributor: fullname: Goto – volume: 25 start-page: 439 year: 2016 end-page: 445 ident: b0010 article-title: Epidemiology of Lung Cancer publication-title: Surg. Oncol. Clin. N. Am. contributor: fullname: Krasna – volume: 23 start-page: 714 year: 2018 ident: b0040 article-title: Development and Validation of a HPLC-ESI-MS/MS Method for Simultaneous Quantification of Fourteen Alkaloids in Mouse Plasma after Oral Administration of the Extract of Corydalis yanhusuo Tuber: Application to Pharmacokinetic Study publication-title: Molecules contributor: fullname: Zhou – volume: 63 start-page: 11 year: 2013 end-page: 30 ident: b0015 article-title: Cancer statistics, 2013 publication-title: CA Cancer J. Clin. contributor: fullname: Jemal – volume: 22 start-page: 496 year: 2015 Apr end-page: 502 ident: b0160 article-title: Different pathways of macrophage activation and polarization publication-title: Postepy. Hig. Med. Dosw. (Online). contributor: fullname: Myśliwska – volume: 39 start-page: 579 year: 2011 end-page: 586 ident: b0110 article-title: Corydalis yanhusuo W.T. Wang extract inhibits MCF-7 cell proliferation by inducing cell cycle G2/M arrest publication-title: Am. J. Chin. Med. contributor: fullname: Wang – volume: 218 start-page: 1336 year: 2013 Nov end-page: 1344 ident: b0165 article-title: Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms publication-title: Immunobiology contributor: fullname: Nagy – volume: 10 start-page: 1117 year: 2008 end-page: 1121 ident: b0100 article-title: Two new protoberberine quaternary alkaloids from Corydalis yanhusuo publication-title: J. Asian Nat. Prod. Res. contributor: fullname: Sun – volume: 233 start-page: 6425 year: 2018 Sep end-page: 6440 ident: b0140 article-title: Macrophage plasticity, polarization, and function in health and disease publication-title: J. Cell Physiol. contributor: fullname: Sahebkar – volume: 36 start-page: 2526 year: 2016 end-page: 2534 ident: b0115 article-title: 13-Methyl-palmatrubine induces apoptosis and cell cycle arrest in A549 cells in vitro and in vivo publication-title: Oncol. Rep. contributor: fullname: Du – volume: 4 start-page: 376 year: 2012 end-page: 389 ident: b0130 article-title: Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer publication-title: Am. J. Transl. Res. contributor: fullname: Eruslanov – volume: 13 start-page: 1 issue: 1 year: 2018 ident: 10.1016/j.intimp.2021.108468_b0030 article-title: Staging of Non-Small-Cell Lung Cancer publication-title: PET Clin. doi: 10.1016/j.cpet.2017.09.004 contributor: fullname: Akhurst – volume: 19 issue: 1 year: 2019 ident: 10.1016/j.intimp.2021.108468_b0105 article-title: Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling publication-title: BMC Complement Altern. Med. doi: 10.1186/s12906-019-2739-6 contributor: fullname: Wan – volume: 4 start-page: 376 issue: 4 year: 2012 ident: 10.1016/j.intimp.2021.108468_b0130 article-title: Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer publication-title: Am. J. Transl. Res. contributor: fullname: Quatromoni – volume: 22 start-page: 496 issue: 69 year: 2015 ident: 10.1016/j.intimp.2021.108468_b0160 article-title: Different pathways of macrophage activation and polarization publication-title: Postepy. Hig. Med. Dosw. (Online). doi: 10.5604/17322693.1150133 contributor: fullname: Juhas – year: 2019 ident: 10.1016/j.intimp.2021.108468_b0055 article-title: Tumor-associated macrophages affect the biological behavior of lung adenocarcinoma A549 cells through the PI3K/AKT signaling pathway publication-title: Oncol. Lett. contributor: fullname: Yuan – volume: 311 start-page: 86 year: 2017 ident: 10.1016/j.intimp.2021.108468_b0075 article-title: Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages publication-title: Cell Immunol. doi: 10.1016/j.cellimm.2016.11.002 contributor: fullname: Sun – volume: 8 start-page: 187 issue: 3 year: 2008 ident: 10.1016/j.intimp.2021.108468_b0180 article-title: The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications publication-title: Curr Cancer Drug Targets doi: 10.2174/156800908784293659 contributor: fullname: Carnero – volume: 25 start-page: 439 issue: 3 year: 2016 ident: 10.1016/j.intimp.2021.108468_b0010 article-title: Epidemiology of Lung Cancer publication-title: Surg. Oncol. Clin. N. Am. doi: 10.1016/j.soc.2016.02.001 contributor: fullname: Mao – volume: 7 start-page: 34217 issue: 23 year: 2016 ident: 10.1016/j.intimp.2021.108468_b0060 article-title: Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis publication-title: Oncotarget. doi: 10.18632/oncotarget.9079 contributor: fullname: Mei – volume: 36 start-page: 2526 issue: 5 year: 2016 ident: 10.1016/j.intimp.2021.108468_b0115 article-title: 13-Methyl-palmatrubine induces apoptosis and cell cycle arrest in A549 cells in vitro and in vivo publication-title: Oncol. Rep. doi: 10.3892/or.2016.5093 contributor: fullname: Chen – volume: 111 start-page: 47 issue: 1 year: 2020 ident: 10.1016/j.intimp.2021.108468_b0200 article-title: Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer publication-title: Cancer Sci. doi: 10.1111/cas.14230 contributor: fullname: Li – volume: 20 start-page: 819 issue: 4 year: 2008 ident: 10.1016/j.intimp.2021.108468_b0050 article-title: Yanhusuo extract inhibits metastasis of breast cancer cells by modulating mitogen-activated protein kinase signaling pathways publication-title: Oncol. Rep. contributor: fullname: Gao – volume: 39 start-page: 1588 issue: 11 year: 2016 ident: 10.1016/j.intimp.2021.108468_b0125 article-title: Diverse macrophages polarization in tumor microenvironment publication-title: Arch. Pharm. Res. doi: 10.1007/s12272-016-0820-y contributor: fullname: Rhee – volume: 8 start-page: 577 issue: 15 year: 2015 ident: 10.1016/j.intimp.2021.108468_b0145 article-title: M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide publication-title: BMC Cancer. doi: 10.1186/s12885-015-1546-9 contributor: fullname: Genin – volume: 8 start-page: 41670 issue: 25 year: 2017 ident: 10.1016/j.intimp.2021.108468_b0090 article-title: Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidence publication-title: Oncotarget doi: 10.18632/oncotarget.16471 contributor: fullname: Pöttgen – volume: 98 start-page: 479 issue: 3 year: 2013 ident: 10.1016/j.intimp.2021.108468_b0170 article-title: AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids publication-title: Cardiovasc Res. doi: 10.1093/cvr/cvt073 contributor: fullname: Namgaladze – volume: 10 start-page: 1117 issue: 11–12 year: 2008 ident: 10.1016/j.intimp.2021.108468_b0100 article-title: Two new protoberberine quaternary alkaloids from Corydalis yanhusuo publication-title: J. Asian Nat. Prod. Res. doi: 10.1080/10286020802410615 contributor: fullname: Cheng – volume: 385 start-page: 977 issue: 9972 year: 2015 ident: 10.1016/j.intimp.2021.108468_b0020 article-title: Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) publication-title: Lancet doi: 10.1016/S0140-6736(14)62038-9 contributor: fullname: Allemani – volume: 50 start-page: 545 issue: 2 year: 2017 ident: 10.1016/j.intimp.2021.108468_b0150 article-title: Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway publication-title: Int. J. Oncol. doi: 10.3892/ijo.2017.3841 contributor: fullname: Kang – year: 2020 ident: 10.1016/j.intimp.2021.108468_b0195 article-title: NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation [published online ahead of print, 2020 Jun 25] publication-title: Cell Biol Int. contributor: fullname: Kang – volume: 23 start-page: 714 issue: 4 year: 2018 ident: 10.1016/j.intimp.2021.108468_b0040 article-title: Development and Validation of a HPLC-ESI-MS/MS Method for Simultaneous Quantification of Fourteen Alkaloids in Mouse Plasma after Oral Administration of the Extract of Corydalis yanhusuo Tuber: Application to Pharmacokinetic Study publication-title: Molecules doi: 10.3390/molecules23040714 contributor: fullname: Du – volume: 39 start-page: 579 issue: 3 year: 2011 ident: 10.1016/j.intimp.2021.108468_b0110 article-title: Corydalis yanhusuo W.T. Wang extract inhibits MCF-7 cell proliferation by inducing cell cycle G2/M arrest publication-title: Am. J. Chin. Med. doi: 10.1142/S0192415X11009044 contributor: fullname: Xu – volume: 38 start-page: 696 year: 2018 ident: 10.1016/j.intimp.2021.108468_b0080 article-title: “My Patient Was Diagnosed With Nontargetable Advanced Non-Small Cell Lung Cancer. What Now?” Diagnosis and Initial Treatment Options for Newly Diagnosed Patients With Advanced NSCLC publication-title: Am. Soc. Clin. Oncol. Educ. Book. doi: 10.1200/EDBK_201231 contributor: fullname: Johnson – volume: 218 start-page: 1336 issue: 11 year: 2013 ident: 10.1016/j.intimp.2021.108468_b0165 article-title: Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms publication-title: Immunobiology doi: 10.1016/j.imbio.2013.06.011 contributor: fullname: Nagy – volume: 10 issue: 6 year: 2019 ident: 10.1016/j.intimp.2021.108468_b0155 article-title: M2 macrophages promote NSCLC metastasis by upregulating CRYAB publication-title: Cell Death Dis. doi: 10.1038/s41419-019-1618-x contributor: fullname: Guo – volume: 233 start-page: 6425 issue: 9 year: 2018 ident: 10.1016/j.intimp.2021.108468_b0140 article-title: Macrophage plasticity, polarization, and function in health and disease publication-title: J. Cell Physiol. doi: 10.1002/jcp.26429 contributor: fullname: Shapouri-Moghaddam – volume: 133 start-page: 121 year: 2018 ident: 10.1016/j.intimp.2021.108468_b0070 article-title: Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2018.05.002 contributor: fullname: Yao – volume: 25 start-page: 601 issue: 3 year: 2016 ident: 10.1016/j.intimp.2021.108468_b0095 article-title: Targeted Therapy and Immunotherapy for Lung Cancer publication-title: Surg. Oncol. Clin. N. Am. doi: 10.1016/j.soc.2016.02.011 contributor: fullname: Naylor – volume: 20 start-page: 3917 issue: 4 year: 2019 ident: 10.1016/j.intimp.2021.108468_b0190 article-title: Increased lncRNA HOTAIR expression promotes the chemoresistance of multiple myeloma to dexamethasone by regulating cell viability and apoptosis by mediating the JAK2/STAT3 signaling pathway publication-title: Mol Med Rep. contributor: fullname: Guan – volume: 22 start-page: 1077 issue: 5 year: 2009 ident: 10.1016/j.intimp.2021.108468_b0035 article-title: A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity publication-title: Oncol. Rep. contributor: fullname: Gao – volume: 42 start-page: 717 issue: 6 year: 2006 ident: 10.1016/j.intimp.2021.108468_b0135 article-title: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy publication-title: Eur. J. Cancer. doi: 10.1016/j.ejca.2006.01.003 contributor: fullname: Sica – volume: 17 start-page: 519 issue: 11–12 year: 2009 ident: 10.1016/j.intimp.2021.108468_b0045 article-title: Angiogenic pathway inhibition of Corydalis yanhusuo and berberine in human umbilical vein endothelial cells publication-title: Oncol. Res. doi: 10.3727/096504009789745575 contributor: fullname: Gao – volume: 2019 start-page: 1 year: 2019 ident: 10.1016/j.intimp.2021.108468_b0085 article-title: The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression publication-title: J. Immunol. Res. contributor: fullname: Lee – volume: 241 start-page: 534 issue: 4 year: 2017 ident: 10.1016/j.intimp.2021.108468_b0205 article-title: Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation publication-title: J Pathol. doi: 10.1002/path.4860 contributor: fullname: De Beule – volume: 5 start-page: 469 issue: 7 year: 1982 ident: 10.1016/j.intimp.2021.108468_b0120 article-title: Antitumor activity of 13-methyl-berberrubine derivatives publication-title: J. Pharmacobiodyn. doi: 10.1248/bpb1978.5.469 contributor: fullname: Ikekawa – volume: 553 start-page: 446 issue: 7689 year: 2018 ident: 10.1016/j.intimp.2021.108468_b0025 article-title: The biology and management of non-small cell lung cancer publication-title: Nature doi: 10.1038/nature25183 contributor: fullname: Herbst – volume: 77 start-page: 4414 issue: 16 year: 2017 ident: 10.1016/j.intimp.2021.108468_b0185 article-title: MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-16-2874 contributor: fullname: Tripathi – volume: 12 start-page: 8055 year: 2019 ident: 10.1016/j.intimp.2021.108468_b0065 article-title: TCF-4 Regulated lncRNA-XIST Promotes M2 Polarization Of Macrophages And Is Associated With Lung Cancer publication-title: Onco. Targets Ther. doi: 10.2147/OTT.S210952 contributor: fullname: Sun – volume: 63 start-page: 11 issue: 1 year: 2013 ident: 10.1016/j.intimp.2021.108468_b0015 article-title: Cancer statistics, 2013 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21166 contributor: fullname: Siegel – volume: 11 start-page: 1362 issue: 9 year: 2011 ident: 10.1016/j.intimp.2021.108468_b0175 article-title: Dehydrocorydaline inhibits elevated mitochondrial membrane potential in lipopolysaccharide-stimulated macrophages publication-title: Int Immunopharmacol. doi: 10.1016/j.intimp.2011.04.022 contributor: fullname: Ishiguro – volume: 136 start-page: E359 issue: 5 year: 2015 ident: 10.1016/j.intimp.2021.108468_b0005 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int. J. Cancer. doi: 10.1002/ijc.29210 contributor: fullname: Ferlay |
SSID | ssj0017041 |
Score | 2.4244025 |
Snippet | •13MP reduced the malignant behaviors of NSCLC cells.•13MP promoted TAM from M2 to M1 polarization.•13MP attenuated M2-TAM-mediated NSCLC progression.•13MP... Previous studies have substantiated that M2-activated tumor-associated macrophages (M2-TAMs) are involved in multiple malignancies. Presently, we probe the... Background Previous studies have substantiated that M2-activated tumor-associated macrophages (M2-TAMs) are involved in multiple malignancies. Presently, we... BACKGROUNDPrevious studies have substantiated that M2-activated tumor-associated macrophages (M2-TAMs) are involved in multiple malignancies. Presently, we... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 108468 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase 13-Methyl-Palmatrubine AKT protein Angiogenesis Animals Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Apoptosis Berberine Alkaloids - pharmacology Berberine Alkaloids - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - immunology Carcinoma, Non-Small-Cell Lung - metabolism Cell culture Cell Line Cell Movement - drug effects Cell proliferation Cell Proliferation - drug effects Cell viability Coculture Techniques Cytokines - genetics Endothelial cells Epithelial-Mesenchymal Transition - drug effects Gelatinase B Humans Immunofluorescence Interleukin 13 Interleukin 4 Lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - immunology Lung Neoplasms - metabolism Macrophage Macrophages Mesenchyme Mice Mice, Inbred BALB C Mice, Nude Non-small cell lung cancer Non-small cell lung carcinoma Polarization Reverse transcription Small cell lung carcinoma Stat3 protein Tumor-Associated Macrophages - drug effects Tumor-Associated Macrophages - immunology Tumors Umbilical vein Vascular endothelial growth factor |
Title | 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages |
URI | https://dx.doi.org/10.1016/j.intimp.2021.108468 https://www.ncbi.nlm.nih.gov/pubmed/35066343 https://www.proquest.com/docview/2639711476 https://search.proquest.com/docview/2622472227 |
Volume | 104 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtymAvY-u-snXlBqNP1RJ9WLIeS1nJNlIKa6FvRnZk6uHYJnY28rK3_d87RXbKYGMw8JNtiUP39Tvp7kTIuziWEVtgdBIZ1CaZxjlF1KooF8ZFUSZTs72HbH6pZjfy0210u0fOh1oYn1bZ2_5g07fWun8z6Vdz0hTF5AtGHhrRssGgBX2YjPfJAbojKUfk4Ozj59nl7jBBT2Vom4o2wQ8YKui2aV5F1RVL37iSM59vJ33P1T97qL8h0K0nunhMHvUQEs4ClU_InqsOyYNwqeTmkJxchW7Um1O4vi-uak_hBK7u-1RvnpKfTNC5Q0aVtLElItfVGsNkB-1d_b0FW-HTFbRbL-sV-CREKCqo6oq2S1uW4Hf8oURTAZkXnBV8KywOLXKfRw1zDl0NcwaND537Wk-ocwjTIRGrurlDW9Y-IzcXH67PZ7S_lYFmwkw7yqzQmnGtF1xlVmnUYWYyZ-w0E06mLFUqx6AKjVcslE25SK2JFplZcJbmCA_FczJCYt1LAhnPc2el7wE2lRlzsWU4W6yUESgqXI8JHTiRNKH5RjJkpX1NAucSz7kkcG5M9MCu5DchStA__GPk0cDdpFfiNuH-0BPjRa3G5O3uM6qfX2FbuXrt_0EMpH1B8Zi8CFKxI1VEHs9J8eq_yXpNHnJfbrHNeTsiIxQE9wZBUJcek_33P9hxL-q_AG9jBKA |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBddythextZ9Zes2DUafKhJ92LIeS1lJ1zoUlkLfhOzI1MOxTey05A_Y_72TZacMNgYDP9mWOHRfv5PuTgh9iSIR0CVEJ4ECbRJJlBFArSFhXNkgSEWiunvI4nk4uxbfboKbPXQ61MK4tMre9nub3lnr_s2kX81JneeT7xB5SEDLCoIW8GEieoT2RSApG6H9k_OL2Xx3mCCnwrdNBZvgBgwVdF2aV162-co1rmTU5dsJ13P1zx7qbwi080Rnz9GzHkLiE0_lC7RnywP02F8quT1AR1e-G_X2GC8eiquaY3yErx76VG9fop-Uk9gCowpSmwKQ63oDYbLFzW1132BTwtPmpN2sqjV2SYg4L3FZlaRZmaLAbscfF2AqcOoEZ43vcgND88zlUeOY4bbCMcW1C537Wk9cZdhPB0Ssq_oWbFnzCl2ffV2czkh_KwNJuZq2hBouYZWlXLIwNaEEHaYqtcpMU25FQpMwzCCoAuMV8dAkjCdGBctULRlNMoCH_DUaAbH2LcIpyzJrhOsBNhUptZGhMFsUhoqDqDA5RmTghK598w09ZKX90J5z2nFOe86NkRzYpX8TIg3-4R8jDwfu6l6JG83coSfEizIco8-7z6B-boVNaauN-wcwkHQFxWP0xkvFjlQeODwn-Lv_JusTejJbxJf68nx-8R49Za70ost_O0QjEAr7AQBRm3zsBf4XsDoGkA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=13-Methyl-palmatrubine+shows+an+anti-tumor+role+in+non-small+cell+lung+cancer+via+shifting+M2+to+M1+polarization+of+tumor+macrophages&rft.jtitle=International+immunopharmacology&rft.au=Wu%2C+Zhihui&rft.au=Zhou%2C+Juan&rft.au=Chen%2C+Fangwei&rft.au=Yu%2C+Jing&rft.date=2022-03-01&rft.eissn=1878-1705&rft.volume=104&rft.spage=108468&rft.epage=108468&rft_id=info:doi/10.1016%2Fj.intimp.2021.108468&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1567-5769&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1567-5769&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1567-5769&client=summon |